Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap424.05M
Market cap424.05M
Price-Earnings ratio-10.30
Price-Earnings ratio-10.30
Dividend yield—
Dividend yield—
Average volume130.20K
Average volume130.20K
High today$2.82
High today$2.82
Low today$2.75
Low today$2.75
Open price$2.77
Open price$2.77
Volume5.02K
Volume5.02K
52 Week high$3.53
52 Week high$3.53
52 Week low$1.32
52 Week low$1.32
IMMP News
TipRanks 2d
Immutep initiated with an Outperform at CitizensCitizens initiated coverage of Immutep (IMMP) with an Outperform rating and $6 price target The firm says the company’s eftilagimod alpha has demonstrated “stro...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.